Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
46.45
-0.43 (-0.92%)
At close: May 9, 2025, 4:00 PM
46.47
+0.02 (0.04%)
After-hours: May 9, 2025, 7:59 PM EDT
BMY Revenue
Bristol-Myers Squibb Company had revenue of $11.20B in the quarter ending March 31, 2025, a decrease of -5.60%. This brings the company's revenue in the last twelve months to $47.64B, up 4.62% year-over-year. In the year 2024, Bristol-Myers Squibb Company had annual revenue of $48.30B with 7.32% growth.
Revenue (ttm)
$47.64B
Revenue Growth
+4.62%
P/S Ratio
1.98
Revenue / Employee
$1,396,950
Employees
34,100
Market Cap
94.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 48.30B | 3.29B | 7.32% |
| Dec 31, 2023 | 45.01B | -1.15B | -2.50% |
| Dec 31, 2022 | 46.16B | -226.00M | -0.49% |
| Dec 31, 2021 | 46.39B | 3.87B | 9.09% |
| Dec 31, 2020 | 42.52B | 16.37B | 62.62% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
BMY News
- 10 hours ago - Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label - Reuters
- 1 day ago - Dividend Harvesting Portfolio Week 218: $21,800 Allocated, $2,195.04 In Projected Dividends - Seeking Alpha
- 3 days ago - Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
- 3 days ago - Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer - Business Wire
- 4 days ago - Bristol Myers to invest $40 billion in the US over 5 years, CEO says - Reuters
- 11 days ago - Top 3 Health Care Stocks That May Rocket Higher In April - Benzinga
- 11 days ago - Retirement Strategy: 2 Blue Chip Dividends Now Way Too Cheap - Seeking Alpha
- 14 days ago - 5 Positives From Bristol-Myers Squibb's Q1 2025 Results - Seeking Alpha